Eydelman Mikhail has filed 99 insider transactions across 1 company since January 2024.
Most recent transaction: a option exercise of 5000 shares of Vaxcyte, Inc. ($PCVX) on March 05, 2025.
Activity breakdown: 0 open-market purchases and 55 sales.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| March 5, 2025 | Vaxcyte, Inc. | $PCVX | Eydelman Mikhail | SVP, GEN COUNSEL & CORP SEC | M | Common Stock | 5000 | $21.41 | 46,620.0000 | 121,997,348 | 12.01% | 0.00% |
| March 5, 2025 | Vaxcyte, Inc. | $PCVX | Eydelman Mikhail | SVP, GEN COUNSEL & CORP SEC | S | Common Stock | 2621 | $70.39 | 43,999.0000 | 121,997,348 | 5.62% | 0.00% |
| March 5, 2025 | Vaxcyte, Inc. | $PCVX | Eydelman Mikhail | SVP, GEN COUNSEL & CORP SEC | S | Common Stock | 2267 | $71.07 | 41,732.0000 | 121,997,348 | 5.15% | 0.00% |
| March 5, 2025 | Vaxcyte, Inc. | $PCVX | Eydelman Mikhail | SVP, GEN COUNSEL & CORP SEC | S | Common Stock | 112 | $72.37 | 41,620.0000 | 121,997,348 | 0.27% | 0.00% |
| March 5, 2025 | Vaxcyte, Inc. | $PCVX | Eydelman Mikhail | SVP, GEN COUNSEL & CORP SEC | M | Stock Option (right to buy) | 5000 | $0.00 | 144,497.0000 | 121,997,348 | 3.34% | 0.00% |
| Feb. 27, 2025 | Vaxcyte, Inc. | $PCVX | Eydelman Mikhail | SVP, GEN COUNSEL & CORP SEC | A | Common Stock | 14484 | $0.00 | 42,706.0000 | 121,997,348 | 51.32% | 0.01% |
| Feb. 28, 2025 | Vaxcyte, Inc. | $PCVX | Eydelman Mikhail | SVP, GEN COUNSEL & CORP SEC | F | Common Stock | 470 | $73.02 | 42,236.0000 | 121,997,348 | 1.10% | 0.00% |
| March 3, 2025 | Vaxcyte, Inc. | $PCVX | Eydelman Mikhail | SVP, GEN COUNSEL & CORP SEC | F | Common Stock | 616 | $72.10 | 41,620.0000 | 121,997,348 | 1.46% | 0.00% |
| Feb. 27, 2025 | Vaxcyte, Inc. | $PCVX | Eydelman Mikhail | SVP, GEN COUNSEL & CORP SEC | A | Stock Option (right to buy) | 48357 | $0.00 | 48,357.0000 | 121,997,348 | 9999.99% | 0.04% |
| Feb. 5, 2025 | Vaxcyte, Inc. | $PCVX | Eydelman Mikhail | SVP, GEN COUNSEL & CORP SEC | M | Common Stock | 5000 | $21.41 | 33,222.0000 | 121,997,348 | 17.72% | 0.00% |
| Feb. 5, 2025 | Vaxcyte, Inc. | $PCVX | Eydelman Mikhail | SVP, GEN COUNSEL & CORP SEC | S | Common Stock | 571 | $87.77 | 32,651.0000 | 121,997,348 | 1.72% | 0.00% |
| Feb. 5, 2025 | Vaxcyte, Inc. | $PCVX | Eydelman Mikhail | SVP, GEN COUNSEL & CORP SEC | S | Common Stock | 635 | $89.09 | 32,016.0000 | 121,997,348 | 1.94% | 0.00% |
| Feb. 5, 2025 | Vaxcyte, Inc. | $PCVX | Eydelman Mikhail | SVP, GEN COUNSEL & CORP SEC | S | Common Stock | 1755 | $89.95 | 30,261.0000 | 121,997,348 | 5.48% | 0.00% |
| Feb. 5, 2025 | Vaxcyte, Inc. | $PCVX | Eydelman Mikhail | SVP, GEN COUNSEL & CORP SEC | S | Common Stock | 1784 | $91.05 | 28,477.0000 | 121,997,348 | 5.90% | 0.00% |
| Feb. 5, 2025 | Vaxcyte, Inc. | $PCVX | Eydelman Mikhail | SVP, GEN COUNSEL & CORP SEC | S | Common Stock | 255 | $91.71 | 28,222.0000 | 121,997,348 | 0.90% | 0.00% |
| Feb. 5, 2025 | Vaxcyte, Inc. | $PCVX | Eydelman Mikhail | SVP, GEN COUNSEL & CORP SEC | M | Stock Option (right to buy) | 5000 | $0.00 | 149,497.0000 | 121,997,348 | 3.24% | 0.00% |
| Jan. 6, 2025 | Vaxcyte, Inc. | $PCVX | Eydelman Mikhail | SVP, GEN COUNSEL & CORP SEC | M | Common Stock | 5000 | $21.41 | 33,222.0000 | 121,997,348 | 17.72% | 0.00% |
| Jan. 6, 2025 | Vaxcyte, Inc. | $PCVX | Eydelman Mikhail | SVP, GEN COUNSEL & CORP SEC | S | Common Stock | 954 | $84.86 | 32,268.0000 | 121,997,348 | 2.87% | 0.00% |
| Jan. 6, 2025 | Vaxcyte, Inc. | $PCVX | Eydelman Mikhail | SVP, GEN COUNSEL & CORP SEC | S | Common Stock | 3921 | $85.73 | 28,347.0000 | 121,997,348 | 12.15% | 0.00% |
| Jan. 6, 2025 | Vaxcyte, Inc. | $PCVX | Eydelman Mikhail | SVP, GEN COUNSEL & CORP SEC | S | Common Stock | 125 | $86.52 | 28,222.0000 | 121,997,348 | 0.44% | 0.00% |
| Jan. 6, 2025 | Vaxcyte, Inc. | $PCVX | Eydelman Mikhail | SVP, GEN COUNSEL & CORP SEC | M | Stock Option (right to buy) | 5000 | $0.00 | 154,497.0000 | 121,997,348 | 3.13% | 0.00% |
| Dec. 5, 2024 | Vaxcyte, Inc. | $PCVX | Eydelman Mikhail | SVP, GEN COUNSEL & CORP SEC | G | Common Stock | 110 | $0.00 | 28,697.0000 | 123,693,461 | 0.38% | 0.00% |
| Dec. 5, 2024 | Vaxcyte, Inc. | $PCVX | Eydelman Mikhail | SVP, GEN COUNSEL & CORP SEC | M | Common Stock | 5000 | $21.41 | 33,697.0000 | 123,693,461 | 17.42% | 0.00% |
| Dec. 5, 2024 | Vaxcyte, Inc. | $PCVX | Eydelman Mikhail | SVP, GEN COUNSEL & CORP SEC | S | Common Stock | 1435 | $90.16 | 32,262.0000 | 123,693,461 | 4.26% | 0.00% |
| Dec. 5, 2024 | Vaxcyte, Inc. | $PCVX | Eydelman Mikhail | SVP, GEN COUNSEL & CORP SEC | S | Common Stock | 3177 | $91.91 | 29,085.0000 | 123,693,461 | 9.85% | 0.00% |
| Dec. 5, 2024 | Vaxcyte, Inc. | $PCVX | Eydelman Mikhail | SVP, GEN COUNSEL & CORP SEC | S | Common Stock | 388 | $92.90 | 28,697.0000 | 123,693,461 | 1.33% | 0.00% |
| Dec. 9, 2024 | Vaxcyte, Inc. | $PCVX | Eydelman Mikhail | SVP, GEN COUNSEL & CORP SEC | F | Common Stock | 475 | $92.06 | 28,222.0000 | 123,693,461 | 1.66% | 0.00% |
| Dec. 5, 2024 | Vaxcyte, Inc. | $PCVX | Eydelman Mikhail | SVP, GEN COUNSEL & CORP SEC | M | Stock Option (right to buy) | 5000 | $0.00 | 159,497.0000 | 123,693,461 | 3.04% | 0.00% |
| Nov. 7, 2024 | Vaxcyte, Inc. | $PCVX | Eydelman Mikhail | SVP, GEN COUNSEL & CORP SEC | A | Performance Stock Option (right to buy) | 26125 | $0.00 | 26,125.0000 | 123,693,461 | 9999.99% | 0.02% |
| Nov. 5, 2024 | Vaxcyte, Inc. | $PCVX | Eydelman Mikhail | SVP, GEN COUNSEL & CORP SEC | M | Common Stock | 5000 | $21.41 | 33,623.0000 | 123,693,461 | 17.47% | 0.00% |
| Nov. 5, 2024 | Vaxcyte, Inc. | $PCVX | Eydelman Mikhail | SVP, GEN COUNSEL & CORP SEC | S | Common Stock | 788 | $104.80 | 32,835.0000 | 123,693,461 | 2.34% | 0.00% |
| Nov. 5, 2024 | Vaxcyte, Inc. | $PCVX | Eydelman Mikhail | SVP, GEN COUNSEL & CORP SEC | S | Common Stock | 1415 | $105.72 | 31,420.0000 | 123,693,461 | 4.31% | 0.00% |
| Nov. 5, 2024 | Vaxcyte, Inc. | $PCVX | Eydelman Mikhail | SVP, GEN COUNSEL & CORP SEC | S | Common Stock | 1524 | $106.82 | 29,896.0000 | 123,693,461 | 4.85% | 0.00% |
| Nov. 5, 2024 | Vaxcyte, Inc. | $PCVX | Eydelman Mikhail | SVP, GEN COUNSEL & CORP SEC | S | Common Stock | 1273 | $107.50 | 28,623.0000 | 123,693,461 | 4.26% | 0.00% |
| Nov. 5, 2024 | Vaxcyte, Inc. | $PCVX | Eydelman Mikhail | SVP, GEN COUNSEL & CORP SEC | M | Stock Option (right to buy) | 5000 | $0.00 | 164,497.0000 | 123,693,461 | 2.95% | 0.00% |
| Oct. 7, 2024 | Vaxcyte, Inc. | $PCVX | Eydelman Mikhail | SVP, GEN COUNSEL & CORP SEC | M | Common Stock | 5000 | $21.41 | 33,623.0000 | 123,693,461 | 17.47% | 0.00% |
| Oct. 7, 2024 | Vaxcyte, Inc. | $PCVX | Eydelman Mikhail | SVP, GEN COUNSEL & CORP SEC | S | Common Stock | 476 | $107.51 | 33,147.0000 | 123,693,461 | 1.42% | 0.00% |
| Oct. 7, 2024 | Vaxcyte, Inc. | $PCVX | Eydelman Mikhail | SVP, GEN COUNSEL & CORP SEC | S | Common Stock | 996 | $108.69 | 32,151.0000 | 123,693,461 | 3.00% | 0.00% |
| Oct. 7, 2024 | Vaxcyte, Inc. | $PCVX | Eydelman Mikhail | SVP, GEN COUNSEL & CORP SEC | S | Common Stock | 3147 | $109.55 | 29,004.0000 | 123,693,461 | 9.79% | 0.00% |
| Oct. 7, 2024 | Vaxcyte, Inc. | $PCVX | Eydelman Mikhail | SVP, GEN COUNSEL & CORP SEC | S | Common Stock | 314 | $110.51 | 28,690.0000 | 123,693,461 | 1.08% | 0.00% |
| Oct. 7, 2024 | Vaxcyte, Inc. | $PCVX | Eydelman Mikhail | SVP, GEN COUNSEL & CORP SEC | S | Common Stock | 67 | $111.68 | 28,623.0000 | 123,693,461 | 0.23% | 0.00% |
| Oct. 7, 2024 | Vaxcyte, Inc. | $PCVX | Eydelman Mikhail | SVP, GEN COUNSEL & CORP SEC | M | Stock Option (right to buy) | 5000 | $0.00 | 169,497.0000 | 123,693,461 | 2.87% | 0.00% |
| Oct. 1, 2024 | Vaxcyte, Inc. | $PCVX | Eydelman Mikhail | SVP, GEN COUNSEL & CORP SEC | M | Common Stock | 5500 | $21.41 | 34,123.0000 | 123,693,461 | 19.22% | 0.00% |
| Oct. 1, 2024 | Vaxcyte, Inc. | $PCVX | Eydelman Mikhail | SVP, GEN COUNSEL & CORP SEC | S | Common Stock | 1414 | $113.38 | 32,709.0000 | 123,693,461 | 4.14% | 0.00% |
| Oct. 1, 2024 | Vaxcyte, Inc. | $PCVX | Eydelman Mikhail | SVP, GEN COUNSEL & CORP SEC | S | Common Stock | 3056 | $114.37 | 29,653.0000 | 123,693,461 | 9.34% | 0.00% |
| Oct. 1, 2024 | Vaxcyte, Inc. | $PCVX | Eydelman Mikhail | SVP, GEN COUNSEL & CORP SEC | S | Common Stock | 1030 | $115.01 | 28,623.0000 | 123,693,461 | 3.47% | 0.00% |
| Oct. 1, 2024 | Vaxcyte, Inc. | $PCVX | Eydelman Mikhail | SVP, GEN COUNSEL & CORP SEC | M | Stock Option (right to buy) | 5500 | $0.00 | 174,497.0000 | 123,693,461 | 3.06% | 0.00% |
| Sept. 3, 2024 | Vaxcyte, Inc. | $PCVX | Eydelman Mikhail | SVP, GEN COUNSEL & CORP SEC | M | Common Stock | 1667 | $21.41 | 32,493.0000 | 97,157,690 | 5.41% | 0.00% |
| Sept. 3, 2024 | Vaxcyte, Inc. | $PCVX | Eydelman Mikhail | SVP, GEN COUNSEL & CORP SEC | S | Common Stock | 4 | $107.67 | 32,489.0000 | 97,157,690 | 0.01% | 0.00% |
| Sept. 3, 2024 | Vaxcyte, Inc. | $PCVX | Eydelman Mikhail | SVP, GEN COUNSEL & CORP SEC | S | Common Stock | 523 | $110.45 | 31,966.0000 | 97,157,690 | 1.61% | 0.00% |
| Sept. 3, 2024 | Vaxcyte, Inc. | $PCVX | Eydelman Mikhail | SVP, GEN COUNSEL & CORP SEC | S | Common Stock | 715 | $111.57 | 31,251.0000 | 97,157,690 | 2.24% | 0.00% |
| Sept. 3, 2024 | Vaxcyte, Inc. | $PCVX | Eydelman Mikhail | SVP, GEN COUNSEL & CORP SEC | S | Common Stock | 122 | $112.66 | 31,129.0000 | 97,157,690 | 0.39% | 0.00% |
| Sept. 3, 2024 | Vaxcyte, Inc. | $PCVX | Eydelman Mikhail | SVP, GEN COUNSEL & CORP SEC | S | Common Stock | 79 | $114.96 | 31,050.0000 | 97,157,690 | 0.25% | 0.00% |
| Sept. 3, 2024 | Vaxcyte, Inc. | $PCVX | Eydelman Mikhail | SVP, GEN COUNSEL & CORP SEC | S | Common Stock | 144 | $116.01 | 30,906.0000 | 97,157,690 | 0.46% | 0.00% |
| Sept. 3, 2024 | Vaxcyte, Inc. | $PCVX | Eydelman Mikhail | SVP, GEN COUNSEL & CORP SEC | S | Common Stock | 80 | $117.28 | 30,826.0000 | 97,157,690 | 0.26% | 0.00% |
| Sept. 3, 2024 | Vaxcyte, Inc. | $PCVX | Eydelman Mikhail | SVP, GEN COUNSEL & CORP SEC | F | Common Stock | 2203 | $110.15 | 28,623.0000 | 97,157,690 | 7.15% | 0.00% |
| Sept. 3, 2024 | Vaxcyte, Inc. | $PCVX | Eydelman Mikhail | SVP, GEN COUNSEL & CORP SEC | M | Stock Option (right to buy) | 1667 | $0.00 | 179,997.0000 | 97,157,690 | 0.92% | 0.00% |
| Aug. 1, 2024 | Vaxcyte, Inc. | $PCVX | Eydelman Mikhail | SVP, GEN COUNSEL & CORP SEC | M | Common Stock | 1667 | $21.41 | 32,493.0000 | 97,157,690 | 5.41% | 0.00% |
| Aug. 1, 2024 | Vaxcyte, Inc. | $PCVX | Eydelman Mikhail | SVP, GEN COUNSEL & CORP SEC | S | Common Stock | 1482 | $78.80 | 31,011.0000 | 97,157,690 | 4.56% | 0.00% |
| Aug. 1, 2024 | Vaxcyte, Inc. | $PCVX | Eydelman Mikhail | SVP, GEN COUNSEL & CORP SEC | S | Common Stock | 185 | $79.29 | 30,826.0000 | 97,157,690 | 0.60% | 0.00% |
| Aug. 1, 2024 | Vaxcyte, Inc. | $PCVX | Eydelman Mikhail | SVP, GEN COUNSEL & CORP SEC | M | Stock Option (right to buy) | 1667 | $0.00 | 181,664.0000 | 97,157,690 | 0.91% | 0.00% |
| July 1, 2024 | Vaxcyte, Inc. | $PCVX | Eydelman Mikhail | SVP, GEN COUNSEL & CORP SEC | M | Common Stock | 1667 | $21.41 | 32,493.0000 | 97,157,690 | 5.41% | 0.00% |
| July 1, 2024 | Vaxcyte, Inc. | $PCVX | Eydelman Mikhail | SVP, GEN COUNSEL & CORP SEC | S | Common Stock | 913 | $75.93 | 31,580.0000 | 97,157,690 | 2.81% | 0.00% |
| July 1, 2024 | Vaxcyte, Inc. | $PCVX | Eydelman Mikhail | SVP, GEN COUNSEL & CORP SEC | S | Common Stock | 754 | $76.90 | 30,826.0000 | 97,157,690 | 2.39% | 0.00% |
| July 1, 2024 | Vaxcyte, Inc. | $PCVX | Eydelman Mikhail | SVP, GEN COUNSEL & CORP SEC | M | Stock Option (right to buy) | 1667 | $0.00 | 183,331.0000 | 97,157,690 | 0.90% | 0.00% |
| June 7, 2024 | Vaxcyte, Inc. | $PCVX | Eydelman Mikhail | SVP, GEN COUNSEL & CORP SEC | F | Common Stock | 335 | $70.97 | 30,826.0000 | 97,157,690 | 1.08% | 0.00% |
| June 3, 2024 | Vaxcyte, Inc. | $PCVX | Eydelman Mikhail | SVP, GEN COUNSEL & CORP SEC | M | Common Stock | 1667 | $21.41 | 32,828.0000 | 97,157,690 | 5.35% | 0.00% |
| June 3, 2024 | Vaxcyte, Inc. | $PCVX | Eydelman Mikhail | SVP, GEN COUNSEL & CORP SEC | S | Common Stock | 751 | $71.25 | 32,077.0000 | 97,157,690 | 2.29% | 0.00% |
| June 3, 2024 | Vaxcyte, Inc. | $PCVX | Eydelman Mikhail | SVP, GEN COUNSEL & CORP SEC | S | Common Stock | 656 | $72.37 | 31,421.0000 | 97,157,690 | 2.05% | 0.00% |
| June 3, 2024 | Vaxcyte, Inc. | $PCVX | Eydelman Mikhail | SVP, GEN COUNSEL & CORP SEC | S | Common Stock | 260 | $73.64 | 31,161.0000 | 97,157,690 | 0.83% | 0.00% |
| June 3, 2024 | Vaxcyte, Inc. | $PCVX | Eydelman Mikhail | SVP, GEN COUNSEL & CORP SEC | M | Stock Option (right to buy) | 1667 | $0.00 | 184,998.0000 | 97,157,690 | 0.89% | 0.00% |
| May 1, 2024 | Vaxcyte, Inc. | $PCVX | Eydelman Mikhail | SVP, GEN COUNSEL & CORP SEC | M | Common Stock | 1667 | $21.41 | 32,264.0000 | 97,157,690 | 5.45% | 0.00% |
| May 1, 2024 | Vaxcyte, Inc. | $PCVX | Eydelman Mikhail | SVP, GEN COUNSEL & CORP SEC | S | Common Stock | 964 | $61.30 | 31,300.0000 | 97,157,690 | 2.99% | 0.00% |
| May 1, 2024 | Vaxcyte, Inc. | $PCVX | Eydelman Mikhail | SVP, GEN COUNSEL & CORP SEC | S | Common Stock | 559 | $61.95 | 30,741.0000 | 97,157,690 | 1.79% | 0.00% |
| May 1, 2024 | Vaxcyte, Inc. | $PCVX | Eydelman Mikhail | SVP, GEN COUNSEL & CORP SEC | S | Common Stock | 144 | $63.90 | 30,597.0000 | 97,157,690 | 0.47% | 0.00% |
| May 1, 2024 | Vaxcyte, Inc. | $PCVX | Eydelman Mikhail | SVP, GEN COUNSEL & CORP SEC | M | Stock Option (right to buy) | 1667 | $0.00 | 186,665.0000 | 97,157,690 | 0.89% | 0.00% |
| April 1, 2024 | Vaxcyte, Inc. | $PCVX | Eydelman Mikhail | SVP, GEN COUNSEL & CORP SEC | M | Common Stock | 1667 | $21.41 | 32,264.0000 | 97,157,690 | 5.45% | 0.00% |
| April 1, 2024 | Vaxcyte, Inc. | $PCVX | Eydelman Mikhail | SVP, GEN COUNSEL & CORP SEC | S | Common Stock | 1397 | $66.59 | 30,867.0000 | 97,157,690 | 4.33% | 0.00% |
| April 1, 2024 | Vaxcyte, Inc. | $PCVX | Eydelman Mikhail | SVP, GEN COUNSEL & CORP SEC | S | Common Stock | 270 | $67.42 | 30,597.0000 | 97,157,690 | 0.87% | 0.00% |
| April 1, 2024 | Vaxcyte, Inc. | $PCVX | Eydelman Mikhail | SVP, GEN COUNSEL & CORP SEC | M | Stock Option (right to buy) | 1667 | $0.00 | 188,332.0000 | 97,157,690 | 0.88% | 0.00% |
| Feb. 29, 2024 | Vaxcyte, Inc. | $PCVX | Eydelman Mikhail | SVP, GEN COUNSEL & CORP SEC | A | Common Stock | 10500 | $0.00 | 31,210.0000 | 97,157,690 | 50.70% | 0.01% |
| March 1, 2024 | Vaxcyte, Inc. | $PCVX | Eydelman Mikhail | SVP, GEN COUNSEL & CORP SEC | M | Common Stock | 1667 | $21.41 | 32,877.0000 | 97,157,690 | 5.34% | 0.00% |
| March 1, 2024 | Vaxcyte, Inc. | $PCVX | Eydelman Mikhail | SVP, GEN COUNSEL & CORP SEC | S | Common Stock | 519 | $73.03 | 32,358.0000 | 97,157,690 | 1.58% | 0.00% |
| March 1, 2024 | Vaxcyte, Inc. | $PCVX | Eydelman Mikhail | SVP, GEN COUNSEL & CORP SEC | S | Common Stock | 703 | $73.59 | 31,655.0000 | 97,157,690 | 2.17% | 0.00% |
| March 1, 2024 | Vaxcyte, Inc. | $PCVX | Eydelman Mikhail | SVP, GEN COUNSEL & CORP SEC | S | Common Stock | 445 | $74.77 | 31,210.0000 | 97,157,690 | 1.41% | 0.00% |
| March 2, 2024 | Vaxcyte, Inc. | $PCVX | Eydelman Mikhail | SVP, GEN COUNSEL & CORP SEC | F | Common Stock | 613 | $71.55 | 30,597.0000 | 97,157,690 | 1.96% | 0.00% |
| Feb. 29, 2024 | Vaxcyte, Inc. | $PCVX | Eydelman Mikhail | SVP, GEN COUNSEL & CORP SEC | A | Stock Option (right to buy) | 50000 | $0.00 | 50,000.0000 | 97,157,690 | 9999.99% | 0.05% |
| March 1, 2024 | Vaxcyte, Inc. | $PCVX | Eydelman Mikhail | SVP, GEN COUNSEL & CORP SEC | M | Stock Option (right to buy) | 1667 | $0.00 | 189,999.0000 | 97,157,690 | 0.87% | 0.00% |
| Feb. 1, 2024 | Vaxcyte, Inc. | $PCVX | Eydelman Mikhail | SVP, GEN COUNSEL & CORP SEC | M | Common Stock | 1667 | $21.41 | 22,377.0000 | 97,157,690 | 8.05% | 0.00% |
| Feb. 1, 2024 | Vaxcyte, Inc. | $PCVX | Eydelman Mikhail | SVP, GEN COUNSEL & CORP SEC | S | Common Stock | 212 | $72.22 | 22,165.0000 | 97,157,690 | 0.95% | 0.00% |
| Feb. 1, 2024 | Vaxcyte, Inc. | $PCVX | Eydelman Mikhail | SVP, GEN COUNSEL & CORP SEC | S | Common Stock | 638 | $73.17 | 21,527.0000 | 97,157,690 | 2.88% | 0.00% |
| Feb. 1, 2024 | Vaxcyte, Inc. | $PCVX | Eydelman Mikhail | SVP, GEN COUNSEL & CORP SEC | S | Common Stock | 343 | $74.11 | 21,184.0000 | 97,157,690 | 1.59% | 0.00% |
| Feb. 1, 2024 | Vaxcyte, Inc. | $PCVX | Eydelman Mikhail | SVP, GEN COUNSEL & CORP SEC | S | Common Stock | 474 | $75.39 | 20,710.0000 | 97,157,690 | 2.24% | 0.00% |
| Feb. 1, 2024 | Vaxcyte, Inc. | $PCVX | Eydelman Mikhail | SVP, GEN COUNSEL & CORP SEC | M | Stock Option (Right to Buy) | 1667 | $0.00 | 191,666.0000 | 97,157,690 | 0.86% | 0.00% |
| Jan. 2, 2024 | Vaxcyte, Inc. | $PCVX | Eydelman Mikhail | SVP, Gen Counsel & Corp Sec | M | Common Stock | 1667 | $21.41 | 22,377.0000 | 97,157,690 | 8.05% | 0.00% |
| Jan. 2, 2024 | Vaxcyte, Inc. | $PCVX | Eydelman Mikhail | SVP, Gen Counsel & Corp Sec | S | Common Stock | 141 | $62.91 | 22,236.0000 | 97,157,690 | 0.63% | 0.00% |
| Jan. 2, 2024 | Vaxcyte, Inc. | $PCVX | Eydelman Mikhail | SVP, Gen Counsel & Corp Sec | S | Common Stock | 598 | $63.59 | 21,638.0000 | 97,157,690 | 2.69% | 0.00% |
| Jan. 2, 2024 | Vaxcyte, Inc. | $PCVX | Eydelman Mikhail | SVP, Gen Counsel & Corp Sec | S | Common Stock | 928 | $64.31 | 20,710.0000 | 97,157,690 | 4.29% | 0.00% |
| Jan. 2, 2024 | Vaxcyte, Inc. | $PCVX | Eydelman Mikhail | SVP, Gen Counsel & Corp Sec | M | Stock Option (right to buy) | 1667 | $0.00 | 193,333.0000 | 97,157,690 | 0.87% | 0.00% |